Global Positron Emission Tomography Nuclear Medicine In Depth Monitoring and Development Analysis

Global Positron Emission Tomography (PET) Nuclear Medicine In-Depth Monitoring and Development Analysis Report 2023

Global Positron Emission Tomography Nuclear Medicine In Depth Monitoring and Development Analysis

Global Positron Emission Tomography (PET) Nuclear Medicine In-Depth Monitoring and Development Analysis Report 2023


The Global Positron Emission Tomography (PET) Nuclear Medicine Market investigation report contains Types, Application & all logical and factual briefs about market Overview, CAGR, Production Volume, Sales, Revenue with the regional analysis covers North America, Europe, Asia-Pacific, South America, Middle East & Africa & The top Players like {playerNamesStr}

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

The global Positron Emission Tomography (PET) Nuclear Medicine market size in 2022 is XX million US dollars, and it is expected to be 27530.0 million US dollars by 2029, with a compound annual growth rate of 15.00% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:

The main players in the Positron Emission Tomography (PET) Nuclear Medicine market include Cardinal Health (U.S.), General Electric (U.S.), Lantheus (U.S.), Bayer AG (Germany), and Bracco Diagnostic Inc. (Italy). The share of the top 3 players in the Positron Emission Tomography (PET) Nuclear Medicine market is XX%.

REGION SHARE:

The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Positron Emission Tomography (PET) Nuclear Medicine market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:

The report segments the market by Type and Application. F-18 accounted for XX% of Positron Emission Tomography (PET) Nuclear Medicine market in 2022. Rb-82 share of XX%.

Oncology accounted for XX% of the Positron Emission Tomography (PET) Nuclear Medicine market in 2022. Cardiology accounts for XX%.

This Positron Emission Tomography (PET) Nuclear Medicine market report provides detailed information on latest developments, trade regulations, value chain optimization, market share, impact of domestic and local market players, analyzes emerging revenue sources, market regulation changes Opportunities in Aspects, Strategic Market Growth Analysis, Market Size, Category Market Growth, Application Areas and Dominance, Product Approvals, Product Launches, Geographic Expansion, Technological Innovations in the Market.

Positron Emission Tomography (PET) Nuclear Medicine market country level analysis

The countries covered in the Positron Emission Tomography (PET) Nuclear Medicine market report include the United States, Canada, Germany, United Kingdom, France, Russia, Japan, China, India, South Korea, Brazil, UAE, Saudi Arabia, etc.

The presence and availability of global brands and challenges due to intense or scarce competition from local and domestic brands, and trade routes are also considered while providing the predictive analysis of country data.

Competitive Landscape and Positron Emission Tomography (PET) Nuclear Medicine Market Share Analysis

Positron Emission Tomography (PET) Nuclear Medicine market competitive landscape provides details by competitors. The detailed information includes company profile, company financials, revenue generated, market potential, R&D investments, new market plans, global reach. The data points presented above relate only to companies relevant to the Positron Emission Tomography (PET) Nuclear Medicine market.

The life sciences industry grows and continues to advance, driving innovation and improving healthcare outcomes for individuals around the world.

Artificial Intelligence (AI) and Machine Learning (ML): AI and ML technologies are increasingly being employed in life sciences research and development. They aid in drug discovery, optimizing clinical trials, analyzing vast amounts of biological data, and identifying patterns that can lead to breakthroughs in understanding diseases and developing new therapies.

Digital Health Technologies: Digital health technologies have seen rapid growth, especially in areas like telemedicine, wearable devices, and mobile health applications. These technologies enable remote patient monitoring, facilitate better healthcare access, and empower individuals to manage their health more effectively.

Wearable Devices and Remote Monitoring: Wearable devices, such as smartwatches and fitness trackers, have become more sophisticated, enabling continuous monitoring of vital signs and health parameters. These devices offer opportunities for early detection of health issues and improved management of chronic conditions.

Highlights-Regions

North America

United States

Canada

Asia Pacific

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Spain

Nordic

South America

Brazil

Argentina

Colombia

Mexico

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

Player list

Cardinal Health (U.S.)

General Electric (U.S.)

Lantheus (U.S.)

Bayer AG (Germany)

Bracco Diagnostic Inc. (Italy)

NorthStar Medical Radioisotopes, LLC (U.S.)

Eckert & Ziegler. (Germany)

Jubilant DraxImage, Inc. (Canada)

PharmaLogic Holdings Corp. (U.S.)

Institute of Isotopes Co., Ltd (Hungary)

SHINE Medical Technologies, LLC (U.S.)

Global Medical Solutions LLC (China)

Segami Corporation (U.S.)

Spectrum Dynamics Medical (Israel)

CMR Naviscan (U.S.)

Shanghai United Imaging Healthcare Co., LTD (China)

Neusoft Corporation (China)

Types list

F-18

Rb-82

Others

Application list

Oncology

Cardiology

Neurology

Other PET Applications

Table of Content

1 Positron Emission Tomography (PET) Nuclear Medicine Market Introduction and Overview

1.1 Positron Emission Tomography (PET) Nuclear Medicine Definition

1.2 Market Size Analysis by Types

1.3 Market Size Analysis by Application

1.4 Research Purposes

1.5 Report Timeline

1.6 Economic Analysis of Global Regions

2 Global Market Growth Trends Analysis

2.1 Global Positron Emission Tomography (PET) Nuclear Medicine Market Size & Forecast (2018-2029)

2.2 Positron Emission Tomography (PET) Nuclear Medicine Growth Trends Analysis by Regions

2.2.1 Positron Emission Tomography (PET) Nuclear Medicine Market Size by Regions: 2018 VS 2023 VS 2029

2.2.2 Positron Emission Tomography (PET) Nuclear Medicine Historic Market Size by Regions (2018-2023)

2.2.3 Positron Emission Tomography (PET) Nuclear Medicine Forecasted Market Size by Regions (2023-2029)

2.2.4 North America Positron Emission Tomography (PET) Nuclear Medicine Market Size & Forecast (2018-2029)

2.2.5 Europe Positron Emission Tomography (PET) Nuclear Medicine Market Size & Forecast (2018-2029)

2.2.6 Asia-Pacific Positron Emission Tomography (PET) Nuclear Medicine Market Size & Forecast (2018-2029)

2.2.7 Latin America Positron Emission Tomography (PET) Nuclear Medicine Market Size & Forecast (2018-2029)

2.2.8 Middle East & Africa Positron Emission Tomography (PET) Nuclear Medicine Market Size & Forecast (2018-2029)

3 North America

3.1 North America Positron Emission Tomography (PET) Nuclear Medicine Revenue by Countries

3.1.1 North America Positron Emission Tomography (PET) Nuclear Medicine Revenue by Countries (2018-2029)

3.2 North America Positron Emission Tomography (PET) Nuclear Medicine Revenue by Players

3.3 North America Positron Emission Tomography (PET) Nuclear Medicine Revenue by Types

3.4 North America Positron Emission Tomography (PET) Nuclear Medicine Revenue by Applications

3.5 United States

3.6 Canada

4 Asia Pacific

4.1 Asia Pacific Positron Emission Tomography (PET) Nuclear Medicine Revenue by Countries

4.1.1 Asia Pacific Positron Emission Tomography (PET) Nuclear Medicine Revenue by Countries (2018-2029)

4.2 Asia Pacific Positron Emission Tomography (PET) Nuclear Medicine Revenue by Players

4.3 Asia Pacific Positron Emission Tomography (PET) Nuclear Medicine Revenue by Types

4.4 Asia Pacific Positron Emission Tomography (PET) Nuclear Medicine Revenue by Applications

4.5 China

4.6 Japan

4.7 Korea

4.8 Southeast Asia

4.9 India

4.10 Australia

5 Europe

5.1 Europe Positron Emission Tomography (PET) Nuclear Medicine Revenue by Countries

5.1.1 Europe Positron Emission Tomography (PET) Nuclear Medicine Revenue by Countries (2018-2029)

5.2 Europe Positron Emission Tomography (PET) Nuclear Medicine Revenue by Players

5.3 Europe Positron Emission Tomography (PET) Nuclear Medicine Revenue by Types

5.4 Europe Positron Emission Tomography (PET) Nuclear Medicine Revenue by Applications

5.5 Germany

5.6 France

5.7 UK

5.8 Italy

5.9 Russia

5.10 Spain

5.11 Nordic

6 Latin America

6.1 Latin America Positron Emission Tomography (PET) Nuclear Medicine Revenue by Countries

6.1.1 Latin America Positron Emission Tomography (PET) Nuclear Medicine Revenue by Countries (2018-2029)

6.2 Latin America Positron Emission Tomography (PET) Nuclear Medicine Revenue by Players

6.3 Latin America Positron Emission Tomography (PET) Nuclear Medicine Revenue by Types

6.4 Latin America Positron Emission Tomography (PET) Nuclear Medicine Revenue by Applications

6.5 Brazil

6.6 Argentina

6.7 Colombia

6.8 Mexico

7 Middle East & Africa

7.1 Middle East & Africa Positron Emission Tomography (PET) Nuclear Medicine Revenue by Countries

7.1.1 Middle East & Africa Positron Emission Tomography (PET) Nuclear Medicine Revenue by Countries (2018-2029)

7.2 Middle East & Africa Positron Emission Tomography (PET) Nuclear Medicine Revenue by Players

7.3 Middle East & Africa Positron Emission Tomography (PET) Nuclear Medicine Revenue by Types

7.4 Middle East & Africa Positron Emission Tomography (PET) Nuclear Medicine Revenue by Applications

7.5 Egypt

7.6 South Africa

7.7 Israel

7.8 Turkey

7.9 GCC Countries

8 Global Positron Emission Tomography (PET) Nuclear Medicine Historical and Forecast Market Analysis by Type

8.1 Global Positron Emission Tomography (PET) Nuclear Medicine Revenue and Market Share by Type

8.2 Global Positron Emission Tomography (PET) Nuclear Medicine Market Forecast by Type (2023-2029)

9 Global Positron Emission Tomography (PET) Nuclear Medicine Historical and Forecast Market Analysis by Application

9.1 Global Positron Emission Tomography (PET) Nuclear Medicine Revenue Market Share by Application (2018-2023)

9.2 Positron Emission Tomography (PET) Nuclear Medicine Market Forecast by Application (2023-2029)

10 Positron Emission Tomography (PET) Nuclear Medicine Industry Dynamic Analysis

10.1 Positron Emission Tomography (PET) Nuclear Medicine Market Trends Analysis

10.2 Positron Emission Tomography (PET) Nuclear Medicine Market Drivers Analysis

10.3 Positron Emission Tomography (PET) Nuclear Medicine Market Challenges Analysis

10.4 Positron Emission Tomography (PET) Nuclear Medicine Market Restraints Analysis

10.5 Positron Emission Tomography (PET) Nuclear Medicine Industry Mergers & Acquisitions

10.6 Positron Emission Tomography (PET) Nuclear Medicine Industry New Entrants and Expansion Plans

11 Players Profiles

11.1 Cardinal Health (U.S.)

11.1.1 Cardinal Health (U.S.) Company Profile

11.1.2 Positron Emission Tomography (PET) Nuclear Medicine Product Overview

11.1.3 Cardinal Health (U.S.) Positron Emission Tomography (PET) Nuclear Medicine Market Performance (2018-2023)

11.1.4 Cardinal Health (U.S.) Business Overview

11.2 General Electric (U.S.)

11.2.1 General Electric (U.S.) Company Profile

11.2.2 Positron Emission Tomography (PET) Nuclear Medicine Product Overview

11.2.3 General Electric (U.S.) Positron Emission Tomography (PET) Nuclear Medicine Market Performance (2018-2023)

11.2.4 General Electric (U.S.) Business Overview

11.3 Lantheus (U.S.)

11.3.1 Lantheus (U.S.) Company Profile

11.3.2 Positron Emission Tomography (PET) Nuclear Medicine Product Overview

11.3.3 Lantheus (U.S.) Positron Emission Tomography (PET) Nuclear Medicine Market Performance (2018-2023)

11.3.4 Lantheus (U.S.) Business Overview

11.4 Bayer AG (Germany)

11.4.1 Bayer AG (Germany) Company Profile

11.4.2 Positron Emission Tomography (PET) Nuclear Medicine Product Overview

11.4.3 Bayer AG (Germany) Positron Emission Tomography (PET) Nuclear Medicine Market Performance (2018-2023)

11.4.4 Bayer AG (Germany) Business Overview

11.5 Bracco Diagnostic Inc. (Italy)

11.5.1 Bracco Diagnostic Inc. (Italy) Company Profile

11.5.2 Positron Emission Tomography (PET) Nuclear Medicine Product Overview

11.5.3 Bracco Diagnostic Inc. (Italy) Positron Emission Tomography (PET) Nuclear Medicine Market Performance (2018-2023)

11.5.4 Bracco Diagnostic Inc. (Italy) Business Overview

11.6 NorthStar Medical Radioisotopes, LLC (U.S.)

11.6.1 NorthStar Medical Radioisotopes, LLC (U.S.) Company Profile

11.6.2 Positron Emission Tomography (PET) Nuclear Medicine Product Overview

11.6.3 NorthStar Medical Radioisotopes, LLC (U.S.) Positron Emission Tomography (PET) Nuclear Medicine Market Performance (2018-2023)

11.6.4 NorthStar Medical Radioisotopes, LLC (U.S.) Business Overview

11.7 Eckert & Ziegler. (Germany)

11.7.1 Eckert & Ziegler. (Germany) Company Profile

11.7.2 Positron Emission Tomography (PET) Nuclear Medicine Product Overview

11.7.3 Eckert & Ziegler. (Germany) Positron Emission Tomography (PET) Nuclear Medicine Market Performance (2018-2023)

11.7.4 Eckert & Ziegler. (Germany) Business Overview

11.8 Jubilant DraxImage, Inc. (Canada)

11.8.1 Jubilant DraxImage, Inc. (Canada) Company Profile

11.8.2 Positron Emission Tomography (PET) Nuclear Medicine Product Overview

11.8.3 Jubilant DraxImage, Inc. (Canada) Positron Emission Tomography (PET) Nuclear Medicine Market Performance (2018-2023)

11.8.4 Jubilant DraxImage, Inc. (Canada) Business Overview

11.9 PharmaLogic Holdings Corp. (U.S.)

11.9.1 PharmaLogic Holdings Corp. (U.S.) Company Profile

11.9.2 Positron Emission Tomography (PET) Nuclear Medicine Product Overview

11.9.3 PharmaLogic Holdings Corp. (U.S.) Positron Emission Tomography (PET) Nuclear Medicine Market Performance (2018-2023)

11.9.4 PharmaLogic Holdings Corp. (U.S.) Business Overview

11.10 Institute of Isotopes Co., Ltd (Hungary)

11.10.1 Institute of Isotopes Co., Ltd (Hungary) Company Profile

11.10.2 Positron Emission Tomography (PET) Nuclear Medicine Product Overview

11.10.3 Institute of Isotopes Co., Ltd (Hungary) Positron Emission Tomography (PET) Nuclear Medicine Market Performance (2018-2023)

11.10.4 Institute of Isotopes Co., Ltd (Hungary) Business Overview

11.11 SHINE Medical Technologies, LLC (U.S.)

11.11.1 SHINE Medical Technologies, LLC (U.S.) Company Profile

11.11.2 Positron Emission Tomography (PET) Nuclear Medicine Product Overview

11.11.3 SHINE Medical Technologies, LLC (U.S.) Positron Emission Tomography (PET) Nuclear Medicine Market Performance (2018-2023)

11.11.4 SHINE Medical Technologies, LLC (U.S.) Business Overview

11.12 Global Medical Solutions LLC (China)

11.12.1 Global Medical Solutions LLC (China) Company Profile

11.12.2 Positron Emission Tomography (PET) Nuclear Medicine Product Overview

11.12.3 Global Medical Solutions LLC (China) Positron Emission Tomography (PET) Nuclear Medicine Market Performance (2018-2023)

11.12.4 Global Medical Solutions LLC (China) Business Overview

11.13 Segami Corporation (U.S.)

11.13.1 Segami Corporation (U.S.) Company Profile

11.13.2 Positron Emission Tomography (PET) Nuclear Medicine Product Overview

11.13.3 Segami Corporation (U.S.) Positron Emission Tomography (PET) Nuclear Medicine Market Performance (2018-2023)

11.13.4 Segami Corporation (U.S.) Business Overview

11.14 Spectrum Dynamics Medical (Israel)

11.14.1 Spectrum Dynamics Medical (Israel) Company Profile

11.14.2 Positron Emission Tomography (PET) Nuclear Medicine Product Overview

11.14.3 Spectrum Dynamics Medical (Israel) Positron Emission Tomography (PET) Nuclear Medicine Market Performance (2018-2023)

11.14.4 Spectrum Dynamics Medical (Israel) Business Overview

11.15 CMR Naviscan (U.S.)

11.15.1 CMR Naviscan (U.S.) Company Profile

11.15.2 Positron Emission Tomography (PET) Nuclear Medicine Product Overview

11.15.3 CMR Naviscan (U.S.) Positron Emission Tomography (PET) Nuclear Medicine Market Performance (2018-2023)

11.15.4 CMR Naviscan (U.S.) Business Overview

11.16 Shanghai United Imaging Healthcare Co., LTD (China)

11.16.1 Shanghai United Imaging Healthcare Co., LTD (China) Company Profile

11.16.2 Positron Emission Tomography (PET) Nuclear Medicine Product Overview

11.16.3 Shanghai United Imaging Healthcare Co., LTD (China) Positron Emission Tomography (PET) Nuclear Medicine Market Performance (2018-2023)

11.16.4 Shanghai United Imaging Healthcare Co., LTD (China) Business Overview

11.17 Neusoft Corporation (China)

11.17.1 Neusoft Corporation (China) Company Profile

11.17.2 Positron Emission Tomography (PET) Nuclear Medicine Product Overview

11.17.3 Neusoft Corporation (China) Positron Emission Tomography (PET) Nuclear Medicine Market Performance (2018-2023)

11.17.4 Neusoft Corporation (China) Business Overview

12 Research Findings and Conclusion

Tables & Figures:
Show more
Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Positron Emission Tomography (PET) Nuclear Medicine Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
What trends are influencing the growth of the Positron Emission Tomography (PET) Nuclear Medicine Market?
New players are entering the Positron Emission Tomography (PET) Nuclear Medicine Market, while established companies are changing their business models and strategies. This pattern is likely to continue for the foreseeable future.
What are the major applications for Positron Emission Tomography (PET) Nuclear Medicine?
Positron Emission Tomography (PET) Nuclear Medicine has a wide range of applications, including and others.
What is the estimated size & growth rate of the Positron Emission Tomography (PET) Nuclear Medicine Market?
In recent years, the Positron Emission Tomography (PET) Nuclear Medicine Market has grown at an incredible rate. From 2025 to 2030, the market is expected to grow at a CAGR of yy%.
What does the future hold for the Positron Emission Tomography (PET) Nuclear Medicine Market?
As the shift to value addition continues, companies in the Positron Emission Tomography (PET) Nuclear Medicine Market face the dual challenge of improving interoperability to optimize performance and experience.
How is the Positron Emission Tomography (PET) Nuclear Medicine Market's changing dynamics captured?
The Positron Emission Tomography (PET) Nuclear Medicine analysis provides high-level qualitative commentary on market dynamics, including information on growth drivers, influential trends, challenges, and opportunities.